Sarah Supsiri
Duke-Robert J. Margolis, MD, Center for Health Policy
518-796-8992 margolisevents@duke.edu
Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle
Registration is closed. This event has already been held.
Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle10000 New Hampshire Avenue, Silver Spring, MD, 20903, US